Metoprolol Metoprolol succinate extended-release tablets are a beta-adrenergic blocker indicated for the treatment of: 4
Grupa farmacoterapeutica: medicamente betablocante; betablocante selective
漢語拼音:Jiushisuan Meituoluo"er Pian
Extended release (metoprolol succinate): Oral: Initial: 50 mg once daily; titrate based on daily evaluation of hemodynamic response to the maximally tolerated dose; maximum dose: 200 mg/day (Ozaydin 2013) Heart failure with reduced ejection fraction (HFrEF): Note: Initiate only in stable patients
trouble breathing
This can damage the blood vessels of the brain, heart, and kidneys, resulting Metoprolol ist gut verträglich, kann aber den Puls stark verlangsamen, zu Asthmaanfällen mit Atemnot, zu Müdigkeit, Kopfschmerzen und Schwindel führen
Metoprolol works by blocking beta-1 adrenergic receptors, explains Michael Goyfman
Metoprolol tartrate is (±)-1- (isopropylamino)-3- [ p - (2-methoxyethyl) phenoxy]-2-propanol (2:1) dextro -tartrate salt, and its structural formula is: Metoprolol tartrate USP is a white, practically odorless, crystalline powder with a molecular weight of 684
1
1 mm], film-coated tablets, debossed with 'C over 74' on one side and deep score line on the other side